Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Current Treatment Options in Oncology|June 12, 2002
Metastatic colorectal cancerH L Kindler, K L ShulmanUrology|February 1, 1996
High-dose continuous intravenous infusion of interleukin-2 therapy for metastatic renal cell carcinoma: the University of Chicago experienceK L Shulman, W M Stadler, N J VogelzangJournal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|April 1, 1993
Adverse reactions to intravenous contrast media in patients treated with interleukin-2K L Shulman, J A Thompson, M C Benyunes, et al.Investigational New Drugs|June 17, 2000
CI-980 in advanced melanoma and hormone refractory prostate cancerC W Ryan, K L Shulman, J M Richards, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 11, 1992
Prolonged continuous intravenous infusion interleukin-2 and lymphokine-activated killer-cell therapy for metastatic renal cell carcinomaJ A Thompson, K L Shulman, M C Benyunes, et al.Investigational New Drugs|June 9, 1999
Phase II trial of uracil/tegafur (UFT) plus leucovorin in patients with advanced hepatocellular carcinomaS Mani, T Schiano, J C Garcia, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 18, 1998
Phase II trial of uracil/tegafur (UFT) plus leucovorin in patients with advanced pancreatic carcinoma: a University of Chicago phase II consortium studyS Mani, J W Kugler, D F Sciortino, et al.Pageof 1